多药耐药结核病预防治疗的可接受性:一个回顾性调查
Emily Lai-Ho MacLean1,2, Yen Ngoc Pham3, Cuong Duc Pham3
1NHMRC Clinical Trials Centre, Faculty of Medicine and Health, University of Sydney, Sydney, Australia.
ERJ open research
|December 24, 2025
概括
这项研究调查了患者在为期6个月的levofloxacin预防性治疗多药耐药结核病的经验. 虽然通常可以接受,但大多数患者表示他们不会重复治疗方案.
科学领域:
- 传染性疾病 传染性疾病
- 公共卫生 公共卫生
- 药理学 药理学是指药理学的学科.
背景情况:
- 耐多药结核病 (MDR-TB) 构成了全球重大卫生挑战.
- 预防性治疗方案对于控制MDR-TB传播至关重要.
- 列沃素是用于治疗和预防MDR-TB的关键抗生素.
研究的目的:
- 评估患者的经验和6个月的levofloxacin预防治疗方案对MDR-TB的可接受性.
- 确定影响患者坚持治疗和愿意重复治疗的因素.
主要方法:
- 对完成6个月列沃素预防治疗方案的患者进行回顾性调查.
- 收集有关患者报告的体验,副作用和整体可接受性的数据.
- 分析反应以确定满意度和重新治疗的可能性.
主要成果:
- 六个月的勒沃弗洛克萨辛治疗方案对患者来说是可以接受的.
- 然而,大多数受访者表示不愿再服用该疗法.
- 不愿意的常见原因可能与副作用或持续时间有关,需要进一步调查.
结论:
- 虽然利沃素预防性治疗是可行的,但患者愿意重复治疗是令人担忧的.
- 需要策略来改善患者体验和长期坚持.
- 进一步的研究应该探索替代方案或支持措施,以提高MDR-TB预防治疗的可接受性.
相关概念视频
Pulmonary Tuberculosis V
520
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
520
Pulmonary Tuberculosis IV
467
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
467
Pulmonary Tuberculosis I
801
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
801
Pulmonary Tuberculosis III
884
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
884
Pulmonary Tuberculosis II
1.3K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.3K


